341 related articles for article (PubMed ID: 12684410)
21. KAI1 metastasis suppressor gene is frequently down-regulated in cervical carcinoma.
Liu FS; Chen JT; Dong JT; Hsieh YT; Lin AJ; Ho ES; Hung MJ; Lu CH
Am J Pathol; 2001 Nov; 159(5):1629-34. PubMed ID: 11696423
[TBL] [Abstract][Full Text] [Related]
22. Clinicopathological significance of fragile histidine triad transcription protein expression in endometrial carcinomas.
Segawa T; Sasagawa T; Saijoh K; Inoue M
Clin Cancer Res; 2000 Jun; 6(6):2341-8. PubMed ID: 10873085
[TBL] [Abstract][Full Text] [Related]
23. Relationship between expression of the KAI1 metastasis suppressor and other markers of advanced bladder cancer.
Ow K; Delprado W; Fisher R; Barrett J; Yu Y; Jackson P; Russell PJ
J Pathol; 2000 May; 191(1):39-47. PubMed ID: 10767717
[TBL] [Abstract][Full Text] [Related]
24. Role of tumor metastasis suppressor gene KAI1 in digestive tract carcinomas and cancer cells.
Wu Q; Ji Y; Zhang MQ; Chen YQ; Chen F; Shi DL; Zheng ZH; Huang YJ; Su WJ
Cell Tissue Res; 2003 Nov; 314(2):237-49. PubMed ID: 12955496
[TBL] [Abstract][Full Text] [Related]
25. Motility-related protein (MRP-1/CD9) and KAI1/CD82 expression inversely correlate with lymph node metastasis in oesophageal squamous cell carcinoma.
Uchida S; Shimada Y; Watanabe G; Li ZG; Hong T; Miyake M; Imamura M
Br J Cancer; 1999 Mar; 79(7-8):1168-73. PubMed ID: 10098753
[TBL] [Abstract][Full Text] [Related]
26. Down-regulation of KAI1/CD82 protein expression in oral cancer correlates with reduced disease free survival and overall patient survival.
Farhadieh RD; Smee R; Ow K; Yang JL; Russell PJ; Crouch R; Jackson P; Jacobson IV
Cancer Lett; 2004 Sep; 213(1):91-8. PubMed ID: 15312688
[TBL] [Abstract][Full Text] [Related]
27. Expression of the KAI1 protein in benign prostatic hyperplasia and prostate cancer.
Ueda T; Ichikawa T; Tamaru J; Mikata A; Akakura K; Akimoto S; Imai T; Yoshie O; Shiraishi T; Yatani R; Ito H; Shimazaki J
Am J Pathol; 1996 Nov; 149(5):1435-40. PubMed ID: 8909232
[TBL] [Abstract][Full Text] [Related]
28. Frequent loss of expression of the cyclin-dependent kinase inhibitor p27(Kip1) in estrogen-related Endometrial adenocarcinomas.
Masciullo V; Susini T; Zamparelli A; Bovicelli A; Minimo C; Massi D; Taddei G; Maggiano N; De Iaco P; Ceccaroni M; Bovicelli L; Amunni G; Mancuso S; Scambia G; Giordano A
Clin Cancer Res; 2003 Nov; 9(14):5332-8. PubMed ID: 14614018
[TBL] [Abstract][Full Text] [Related]
29. Expression of a splice variant of KAI1, a tumor metastasis suppressor gene, influences tumor invasion and progression.
Lee JH; Seo YW; Park SR; Kim YJ; Kim KK
Cancer Res; 2003 Nov; 63(21):7247-55. PubMed ID: 14612520
[TBL] [Abstract][Full Text] [Related]
30. Expression and clinical significance of p53, JunB and KAI1/CD82 in human hepatocellular carcinoma.
Guo C; Liu QG; Zhang L; Song T; Yang X
Hepatobiliary Pancreat Dis Int; 2009 Aug; 8(4):389-96. PubMed ID: 19666408
[TBL] [Abstract][Full Text] [Related]
31. KAI1 is unchanged in metastatic and nonmetastatic esophageal and gastric cancers.
Guo XZ; Friess H; Maurer C; Berberat P; Tang WH; Zimmermann A; Naef M; Graber HU; Korc M; Büchler MW
Cancer Res; 1998 Feb; 58(4):753-8. PubMed ID: 9485031
[TBL] [Abstract][Full Text] [Related]
32. Expression of maspin in endometrioid adenocarcinoma of endometrium.
Li HW; Leung SW; Chan CS; Yu MM; Wong YF
Oncol Rep; 2007 Feb; 17(2):393-8. PubMed ID: 17203179
[TBL] [Abstract][Full Text] [Related]
33. Loss of KAI1 expression in gastric cancer.
Tsutsumi S; Shimura T; Morinaga N; Mochiki E; Asao T; Kuwano H
Hepatogastroenterology; 2005; 52(61):281-4. PubMed ID: 15783050
[TBL] [Abstract][Full Text] [Related]
34. Expression of the retinoblastoma-related gene Rb2/p130 is downregulated in atypical endometrial hyperplasia and adenocarcinoma.
Susini T; Massi D; Paglierani M; Masciullo V; Scambia G; Giordano A; Amunni G; Massi G; Taddei GL
Hum Pathol; 2001 Apr; 32(4):360-7. PubMed ID: 11331952
[TBL] [Abstract][Full Text] [Related]
35. KAI1 tetraspanin and metastasis suppressor.
Jackson P; Marreiros A; Russell PJ
Int J Biochem Cell Biol; 2005 Mar; 37(3):530-4. PubMed ID: 15618009
[TBL] [Abstract][Full Text] [Related]
36. Suppression of invasive properties of colon cancer cells by a metastasis suppressor KAI1 gene.
Takaoka A; Hinoda Y; Satoh S; Adachi Y; Itoh F; Adachi M; Imai K
Oncogene; 1998 Mar; 16(11):1443-53. PubMed ID: 9525743
[TBL] [Abstract][Full Text] [Related]
37. Genomic organization of the human KAI1 metastasis-suppressor gene.
Dong JT; Isaacs WB; Barrett JC; Isaacs JT
Genomics; 1997 Apr; 41(1):25-32. PubMed ID: 9126478
[TBL] [Abstract][Full Text] [Related]
38. High expression of PRL-3 promotes cancer cell motility and liver metastasis in human colorectal cancer: a predictive molecular marker of metachronous liver and lung metastases.
Kato H; Semba S; Miskad UA; Seo Y; Kasuga M; Yokozaki H
Clin Cancer Res; 2004 Nov; 10(21):7318-28. PubMed ID: 15534108
[TBL] [Abstract][Full Text] [Related]
39. Down-regulation of PHLDA1 gene expression is associated with breast cancer progression.
Nagai MA; Fregnani JH; Netto MM; Brentani MM; Soares FA
Breast Cancer Res Treat; 2007 Nov; 106(1):49-56. PubMed ID: 17211533
[TBL] [Abstract][Full Text] [Related]
40. KAI1 gene expression in hepatocellular carcinoma and its relationship with intrahepatic metastases.
Sun HC; Tang ZY; Zhou G; Li XM
J Exp Clin Cancer Res; 1998 Sep; 17(3):307-11. PubMed ID: 9894767
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
